PAOLONE, Giovanna
 Distribuzione geografica
Continente #
NA - Nord America 4.473
AS - Asia 3.121
EU - Europa 3.094
SA - Sud America 422
Continente sconosciuto - Info sul continente non disponibili 165
AF - Africa 142
OC - Oceania 11
Totale 11.428
Nazione #
US - Stati Uniti d'America 4.285
RU - Federazione Russa 1.300
SG - Singapore 1.267
CN - Cina 865
IT - Italia 430
GB - Regno Unito 390
BR - Brasile 318
VN - Vietnam 253
HK - Hong Kong 237
IE - Irlanda 202
FR - Francia 200
SE - Svezia 154
DE - Germania 147
KR - Corea 119
CA - Canada 90
TR - Turchia 78
UA - Ucraina 77
NG - Nigeria 67
FI - Finlandia 63
BD - Bangladesh 54
IN - India 52
IL - Israele 44
AR - Argentina 32
MX - Messico 28
ES - Italia 27
ID - Indonesia 25
JP - Giappone 22
NL - Olanda 22
SC - Seychelles 22
AT - Austria 21
EC - Ecuador 20
IQ - Iraq 19
CO - Colombia 17
UZ - Uzbekistan 16
ZA - Sudafrica 15
CR - Costa Rica 14
PK - Pakistan 14
GT - Guatemala 12
BE - Belgio 11
PL - Polonia 11
PR - Porto Rico 11
AU - Australia 9
CW - ???statistics.table.value.countryCode.CW??? 9
SA - Arabia Saudita 9
HN - Honduras 8
MY - Malesia 8
PH - Filippine 8
PY - Paraguay 8
VE - Venezuela 8
KE - Kenya 7
MA - Marocco 7
HU - Ungheria 6
PE - Perù 6
SV - El Salvador 6
DO - Repubblica Dominicana 5
EG - Egitto 5
JO - Giordania 5
TN - Tunisia 5
TW - Taiwan 5
BJ - Benin 4
BO - Bolivia 4
CL - Cile 4
PT - Portogallo 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
JM - Giamaica 3
NI - Nicaragua 3
NP - Nepal 3
PA - Panama 3
RO - Romania 3
RS - Serbia 3
AZ - Azerbaigian 2
CG - Congo 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
ET - Etiopia 2
HR - Croazia 2
IR - Iran 2
KH - Cambogia 2
LT - Lituania 2
ME - Montenegro 2
MK - Macedonia 2
NC - Nuova Caledonia 2
TH - Thailandia 2
AL - Albania 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BZ - Belize 1
CH - Svizzera 1
CY - Cipro 1
GY - Guiana 1
KN - Saint Kitts e Nevis 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
Totale 11.264
Città #
Ashburn 754
Singapore 643
San Jose 594
Moscow 374
Chandler 311
Dallas 303
Jacksonville 291
Southend 284
Council Bluffs 244
Hong Kong 233
Verona 204
Dublin 202
Beijing 162
The Dalles 94
Ho Chi Minh City 88
Lawrence 80
Princeton 80
Jinan 74
Wilmington 70
Los Angeles 66
Abuja 61
Nanjing 59
Shenyang 56
Ann Arbor 55
Milan 52
Santa Clara 51
New York 49
Istanbul 47
Helsinki 45
Redmond 38
Hanoi 37
Seoul 35
Buffalo 33
Hebei 33
São Paulo 33
Columbus 32
Redondo Beach 31
Brooklyn 29
Las Vegas 28
San Francisco 25
Changsha 24
London 24
Guangzhou 23
Montreal 23
Dong Ket 21
Tokyo 21
Zhengzhou 21
Barnet 20
Munich 20
Ningbo 20
Tianjin 18
Bologna 17
Philadelphia 17
Toronto 17
Nanchang 16
Orem 16
Rome 16
Vienna 15
Boston 14
Hangzhou 14
Charlotte 13
Chennai 13
San José 13
Sindelfingen 13
Tashkent 13
Turku 13
Da Nang 12
Denver 12
Haikou 12
Houston 12
Jiaxing 12
Lanzhou 12
Nuremberg 12
Rio de Janeiro 12
Brussels 11
Frankfurt am Main 11
Haiphong 11
Mexico City 11
Shanghai 11
Belo Horizonte 10
Chicago 10
Jakarta 10
Johannesburg 10
Seattle 10
Stockholm 10
Willemstad 9
Woodbridge 9
Amsterdam 8
Brasília 8
Curitiba 8
Guatemala City 8
Phoenix 8
Quito 8
Redwood City 8
Urbana 8
Baghdad 7
Brescia 7
New Delhi 7
North Bergen 7
Roncà 7
Totale 6.763
Nome #
Can single shell diffusion MRI detect synaptic plasticity in mice? 217
Daily performance of a sustained attention task during light phase desynchronizes circadian oscillators in nocturnal rats. 198
Sampling from injured tissue as a blessing in disguise: tonic changes in cholinergic neurotransmission using microdialysis. 190
Frontotemporal dementia as a consequence of GRN mutations: From disease cause to models to therapies 189
Cell Therapy for Epilepsy 186
D-Aspartate oxidase influences glutamatergic system homeostasis in mammalian brain 181
Deficits in the attentional control of posture and complex movements in a rat model of early state, multisystem Parkinson’s disease 179
Circadian pacemaker in “shift worker” rats: Effect of a sustained daily cognitive task on circadian gene expression and corticosterone 177
Encapsulated Cell Therapy for The Treatment of Epilepsy 172
The metaplastic effects of ketamine on sucrose renewal and contextual memory reconsolidation in rats 170
d-Cycloserine facilitates extinction of a cocaine-induced conditioned place preference 166
Cholinergic control over attention in rats prone to attribute incentive salience to reward cues 163
Deficits in attentional control: cholinergic mechanisms and circuits-based treatment approaches 163
An established preference for a conditioned stimulus associated with either sucrose or copulation in male rats subsequently shifts to a preference for a conditioned stimulus paired with cocaine self-administration 161
Deficits in attentional control of balance, mobility, and complex movements in a rat model of early state, multisystem Parkinson disease. 159
Eltoprazine attenuates L-DOPA induced dyskinesia along with GABA and Glutamate release in rat substantia nigra 159
Cognitive performance-associated increases in cholinergic neurotransmission also serve as a circadian signal to sustain performance-induced diurnal activity pattern. 157
Dissociation in the modulatory effects of environmental novelty on the locomotor, analgesic, and eating response to acute and repeated morphine in the rat 157
Cell-laden alginate hydrogels for the treatment of diabetes 155
Reconsolidation of sucrose instrumental memory in rats: the role of retrieval context 153
Encapsulated cell therapy in a rat model of epilepsy: long-term, stable, and efficacious targeting of the hippocampus with GDNF 150
Cytokine-, neurotrophin-, and motor rehabilitation-induced plasticity in Parkinson’s Disease 150
Effects of methadone maintenance on cocaine-motivated behaviour 149
Regulation and function of the tonic component of cortical acetylcholine release 148
Advances in cell-laden hydrogels for delivering therapeutics 148
Glucocorticoids deeply affect spine plasticity and inflammation in an animal model of Alzheimer’s Disease 147
Effects of amount of exposure to cocaine self-administration and time since termination of drug taking on relapse to drug seeking assessed in extinction and follow acute foot-shock stress. 144
Environmental modulation of cocaine self-administration 143
Glucocorticoid receptors modulate dendritic spine plasticity and microglia activity in an animal model of Alzheimer's disease 143
Sign- versus goal trackers, top down control of attention, and underlying cholinergic mechanisms 139
Decision making in frontotemporal dementia: neuropsychological and neuroimaging assessments 137
Paying attention with a compromised cholinergic system: attenuated activation of cholinergic neurotransmission in attentional task-performing CHT+/- mice 136
Ecocebo: how the interaction between environment and drug effects may improve pharmacotherapy outcomes 133
Call to action: Pharmaceutical residues in the environment: threats to ecosystems and human health 132
Effects of the selective alpha 7 nAChR agonist ABT-107 on prefrontal glutamatergic and cholinergic activity and attentional performance 132
Olanzapine, but not clozapine, increases glutamate release in the prefrontal cortex of freely moving mice by inhibiting D-aspartate oxidase activity. 129
Timed, sustained, attention-demanding performance reorganizes or dampens multiple circadian rhythms. 126
Multiple modes of cholinergic neurotransmission - Multiple functions 126
Neurotoxic effects of rotenone and deltamethrin prolonged exposure on adult zebrafish 125
Prior daily practice of a sustained attention task during the light phase evokes a diurnal behavioral activity pattern and a task time-synchronized increase in prefrontal cholinergic neurotransmission 125
Modeling fall propensity in Parkinson's disease: Deficits in the attentional control of complex movements in rats with cortical-cholinergic and striatal-dopaminergic deafferentation 125
Environmental modulation of heroin-induced locomotory activity and Fos expression 123
Effect of inter-trial-interval and duration of exposure on the facilitation of extinction of a cocaine-induced conditioned place preference by d-cycloserine 122
Encapsulated cell therapy for Parkinson`s disease: long-term, stable and efficacious targeting of the nigrostriatal dopaminergic system with GDNF 121
Encapsulated cell therapy for epilepsy: long-term, stable and efficacious targeting of the hippocampus with GDNF 119
Optogenetically-evoked cortical cholinergic transients in mice expressing channelrhodopsin-2 (ChR2) in cholinergic neurons. 119
The facilitative effects of D-Cycloserine on extinction of a cocaine-induced Conditioned Place Preference can be long lasting and resistant to reinstatement: effects of extinction variables 117
Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity 115
Environmental modulation of heroin self-administration 115
Widespread Striatal Delivery of GDNF from Encapsulated Cells Prevents the Anatomical and Functional Consequences of Excitotoxicity 114
Gene therapy device-based delivery of progranulin, prosaposin, and GDNF as a combined precision and neurorestorative therapy in the rat 6-OHDA model of parkinsonism 113
The opioid agonist-antagonist, buprenorphine, preferentially suppresses cocaine self-administration over heroin in rats trained to self-administer both drugs 110
Seizure-Suppressant and Neuroprotective Effects of Encapsulated BDNF-Producing Cells in a Rat Model of Temporal Lobe Epilepsy. 107
Environmental modulation of the interoceptive effects of amphetamine in the rat 107
Environmental modulation of the interoceptive effects of cocaine and morphine 107
Selective potentiation of (α4)3(β2)2 nicotinic acetylcholine receptors augments amplitudes of prefrontal acetylcholine- and nicotine-evoked glutamatergic transients in rats 107
From the Gut to the Brain and Back: Therapeutic Approaches for the Treatment of Network Dysfunction in Parkinson's Disease 107
Monitoring cholinergic activity during attentional performance in mice heterozygous for the choline transporter: a model of cholinergic capacity limits 106
Time to pay attention: attentional performance time-stamped prefrontal cholinergic activation, diurnality, and performance 106
High temporal resolution microdialysis reveals cholinergic spikes preceding upshifts in attentional performance. 106
Environmental novelty enhances the locomotor activating but not the analgesic effects of morphine 105
Where Dopaminergic and Cholinergic Systems Interact: A Gateway for Tuning Neurodegenerative Disorders 105
Environmental novelty facilitates amphetamine discrimination in the rat 104
Environmental modulation of cocaine self-administration in the rat 103
Staying cognitively engaged during the wrong time of the day: cognitive-cholinergic induction and maintenance of diurnality in rats 103
Environmental novelty differentially modulates the locomotor activating versus the analgesic effects of acute and repeated morphine 103
Chronic Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Hormones on the Animal Model Danio Rerio 102
Opposite environmental regulation of heroin and amphetamine self-administration in the rat. 102
Seizures-suppressant effect of encapsulated BDNF-producing cells in a rat model of temporal lobe epilepsy 102
Real-time biosensing of glutamatergic and cholinergic neurotransmission in vivo: implications for psychopharmacology 102
Long-term, stable, targeted biodelivery and efficacy of GDNF from encapsulated cells in the rat and Goettingen miniature pig brain 101
Personalized needles for microinjections in the rodent brain 100
Positive allosteric modulation of α4β2* nicotinic acetylcholine receptors augments the amplitudes of prefrontal nicotine-evoked glutamatergic transients 100
Multiple time scales and variable spaces: synaptic neurotransmission in vivo 99
Correction to: Implication of sestrin3 in epilepsy and its comorbidities 97
Environmental modulation of amphetamine discrimination in the rat 94
Implication of sestrin3 in epilepsy and its comorbidities 94
Poor and Unstable Sustained Attentional Performance in Sign-Trackers: An Animal Model of Poor Top Down Cognitive Control of Attention 93
Repeated exposures to heroin and/or cadmium alter the rate of morphine glucoronides in the rat 93
The facilitative effects of D-Cycloserine on extinction of a cocaine-induced Conditioned Place Preference and Fos Protein Expression in the Pre-Frontal Cortex 92
The facilitative effects of d-cycloserine on extinction of a cocaine-induced conditioned place preference can be long lasting and resistant to reinstatement 92
Long-term, targeted delivery of GDNF from encapsulated cells is neuroprotective and reduces seizures in the pilocarpine model of epilepsy 90
Social isolation selectively reduces hippocampal brain-derived neurotrophic factor without altering plasma corticosterone 89
Modeling the role of environment in addiction 88
Repeated exposures to heroin and/or cadmium alter the rate of formation of morphine glucuronides in the rat 85
Modulatory effect of environmental context and drug history on heroin-induced psychomotor activity and fos protein expression in the rat brain. 83
Environmental modulation of subjective drug effects 79
A narrative review on the environmental impact of medicines: from water analysis and in vivo studies to prescribing appropriateness, based on European and Italian legal frameworks 79
From the Gut to the Brain and Back: Therapeutic Approaches for the Treatment of Network Dysfunction in Parkinson’s Disease 53
null 44
Distinct Transcriptomic Signatures of HIV-1 Tat and gp120 Uncover Differential Neuroimmune Vulnerability in a Gba1-Deficient Synucleinopathy Model 43
Presence of Benzodiazepines in Aquatic Environments: A Systematic Review of the Literature 29
Short-term, high-end environmentally -relevant diazepam exposure induces sex-specific behavioral and molecular alterations in adult zebrafish 27
HIV-1 Tat and gp120 as key drivers of neurodegeneration in the central nervous system 27
Sustainable pharmacy for training and education of pharmacy professionals 17
RNA Splicing Dysregulation in Parkinson's Disease 15
Daily regulation of glucocerebrosidase activity and impact of fixed-time rotarod training in a mouse model of Gba1-associated Parkinson's disease 14
Totale 11.428
Categoria #
all - tutte 39.059
article - articoli 19.561
book - libri 0
conference - conferenze 17.568
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.930
Totale 78.118


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022335 0 0 0 0 16 8 5 59 19 17 17 194
2022/20231.063 93 85 112 188 74 272 23 45 134 9 20 8
2023/2024547 17 38 42 67 47 78 21 75 0 51 76 35
2024/20251.432 80 101 28 217 68 44 53 67 245 110 158 261
2025/20265.103 443 288 356 698 1.066 273 547 287 490 399 57 199
2026/20271.418 78 172 228 740 200 0 0 0 0 0 0 0
Totale 11.428